Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 2821 AL 2835

Glutathione Depletion and MicroRNA Dysregulation in Multiple System Atrophy: A Review

Kinoshita C, Kubota N, Aoyama K.

Int J Mol Sci. 2022 Dec 1;23(23):15076. doi: 10.3390/ijms232315076.

The Role of Epigenetics in Neuroinflammatory-Driven Diseases

Giallongo S, Longhitano L, Denaro S, D'Aprile S, Torrisi F, La Spina E, Giallongo C, Mannino G, Lo Furno D, Zappalà A, Giuffrida R, Parenti R, Li Volti G, Tibullo D, Vicario N.

Int J Mol Sci. 2022 Dec 2;23(23):15218. doi: 10.3390/ijms232315218.

Tau Isoforms: Gaining Insight into MAPT Alternative Splicing

Corsi A, Bombieri C, Valenti MT, Romanelli MG.

Int J Mol Sci. 2022 Dec 6;23(23):15383. doi: 10.3390/ijms232315383.

Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence

Angelopoulou E, Pyrgelis ES, Piperi C.

Molecules. 2022 Dec 2;27(23):8448. doi: 10.3390/molecules27238448.

The Role of Ketogenic Diet in the Treatment of Neurological Diseases

Dyńka D, Kowalcze K, Paziewska A.

Nutrients. 2022 Nov 24;14(23):5003. doi: 10.3390/nu14235003.

The Effects of Dietary Interventions on Brain Aging and Neurological Diseases

Lobo F, Haase J, Brandhorst S.

Nutrients. 2022 Nov 30;14(23):5086. doi: 10.3390/nu14235086.

Prevalence of Malnutrition in Patients with Parkinson's Disease: A Systematic Review

Kacprzyk KW, Milewska M, Zarnowska A, Panczyk M, Rokicka G, Szostak-Wegierek D.

Nutrients. 2022 Dec 6;14(23):5194. doi: 10.3390/nu14235194.

Early-Onset Parkinson's Disease: Creating the Right Environment for a Genetic Disorder

Kolicheski A, Turcano P, Tamvaka N, McLean PJ, Springer W, Savica R, Ross OA.

J Parkinsons Dis. 2022;12(8):2353-2367. doi: 10.3233/JPD-223380.

Dystonia and the pedunculopontine nucleus: Current evidences and potential mechanisms

Su JH, Hu YW, Yang Y, Li RY, Teng F, Li LX, Jin LJ.

Front Neurol. 2022 Nov 23;13:1065163. doi: 10.3389/fneur.2022.1065163. eCollection 2022.

Reviewing the state of the art of probiotics as clinical modalities for brain-gut-microbiota axis associated disorders

Wiegers C, Veerman MA, Brummer RJ, Larsen OFA.

Front Microbiol. 2022 Nov 25;13:1053958. doi: 10.3389/fmicb.2022.1053958. eCollection 2022.

In Silico Studies to Predict the Role of Solvent in Guiding the Conformations of Intrinsically Disordered Peptides and Their Aggregated Protofilaments

Khatua P, Mondal S, Gupta M, Bandyopadhyay S.

ACS Omega. 2022 Nov 21;7(48):43337-43345. doi: 10.1021/acsomega.2c06235. eCollection 2022 Dec 6.

Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules

Bondarev AD, Attwood MM, Jonsson J, Chubarev VN, Tarasov VV, Liu W, Schiöth HB.

Front Pharmacol. 2022 Nov 24;13:1057083. doi: 10.3389/fphar.2022.1057083. eCollection 2022.

miRNA and antisense oligonucleotide-based α-synuclein targeting as disease-modifying therapeutics in Parkinson's disease

Suvarna V, Deshmukh K, Murahari M.

Front Pharmacol. 2022 Nov 15;13:1034072. doi: 10.3389/fphar.2022.1034072. eCollection 2022.

Adverse event profiles of adjuvant treatment with opicapone in Parkinson's disease: A systematic review and meta-analysis

Xie L, Qi X, Wang X, He B, Wang Y, Zhang W, Yu Z, Deng M, Liang S, Lü M.

Front Pharmacol. 2022 Nov 24;13:1042992. doi: 10.3389/fphar.2022.1042992. eCollection 2022.

Pharmacotherapeutic potential of walnut (Juglans spp.) in age-related neurological disorders

Hosseini Adarmanabadi SMH, Karami Gilavand H, Taherkhani A, Sadat Rafiei SK, Shahrokhi M, Faaliat S, Biabani M, Abil E, Ansari A, Sheikh Z, Poudineh M, Khalaji A, ShojaeiBaghini M, Koorangi A, Deravi N.

IBRO Neurosci Rep. 2022 Nov 26;14:1-20. doi: 10.1016/j.ibneur.2022.10.015. eCollection 2023 Jun.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias